Suppressing bcl-2 expression with gene-targeted oligonucleotides facilitated apoptosis induction in tumor cells and increased cell sensitivity to apoptosis-inducing chemotherapeutic drugs [68, 69]. The gene discussed is BCL2; the disease is neoplasm.